MedAutonomic implants device to treat metabolic syndrome

  MedAutonomic said today it has successfully implanted a brain neuromodulation device, the Phoenix, into the stomach wall of a human through an innovative digestive endoscopic procedure. Powered without a battery, the Phoenix sends signals to the limbic system to reset an imbalance in the autonomic nervous system to treat metabolic syndrome and functional diseases such

GE, DARPA are taking on Type 2 diabetes with electricity

GE and DARPA are collaborating on a $2.9 million study of neuromodulation as a treatment for Type 2 diabetes. GE scientists have developed a novel, potentially breakthrough approach that could restore nerve signals to a healthy state using non-invasive devices that stimulate metabolic biosystems and produce drug-like effects, but with greater precision than traditional treatments,

BrainScope lands $4.5M to add vision assessment to its technology

The U.S. Department of Defense has awarded BrainScope a $4.5 million research contract to create and integrate ocular capabilities into its handheld, multi-parameter mild traumatic brain injury (mTBI) and concussion products. The Bethesda, Md.-based company’s initial product, BrainScope One, is the first FDA-cleared medical device that can assess the full spectrum of brain injury – from

BlueWind posts positive follow-up study results

Neurostim developer BlueWind Medical reported positive results from a follow-up study of patients using its implantable tibial nerve stimulator for overactive bladder (OAB). Renova iStim is a leadless, miniature, wireless neurostimulation platform designed for the treatment of multiple clinical indications. Three years after implantation of the BlueWind’s Renova iStim device, 75% of patients experienced at least

$3.8 million federal grant targets suicide research

Researchers using brain imaging to identify people with suicidal thoughts just landed a $3.8 million grant from the National Institute for Mental Health. Marcel Just of Carnegie Mellon University and David Brent of the University of Pittsburgh will use the money to advance their research analyzing the alterations in how brains represent certain concepts, such

LivaNova launches global study of epilepsy treatment

The first patient with drug-resistant epilepsy has received LivaNova’s (NASDAQ:LIVN) vagus nerve stimulation (VNS) therapy system, kicking off enrollment of a global registry to evaluate it, the company said. Drug-resistant epilepsy (DRE) affects nearly one in three people with epilepsy, according to an article in the New England Journal of Medicine. The LivaNova study will

FDA grants expanded clearance for MagVenture’s depression-treating TMS system

Non-invasive magnetic stimulation developer MagVenture said today it won expanded FDA clearance for its transcranial magnetic stimulation system (TMS), now cleared for treatment protocols with shorter treatment sessions. The Atlanta-based company said a new treatment form using its TMS hardware, dubbed theta burst stimulation, can now be provided in three-minute sessions, down from previous treatment protocols which

BrainsWay wins ‘historic milestone’ clearance to treat OCD

BrainsWay said it has won de novo clearance from the FDA for its deep transcranial magnetic stimulation (Deep TMS) system for treatment of obsessive-compulsive disorder (OCD) in adults. The clearance marks the second indication granted for BrainsWay Deep TMS, and the first noninvasive medical device clearance for the treatment of OCD. The FDA  cleared the

SPR Therapeutics’ new PNS system wins FDA nod

The FDA has approved SPR Therapeutics’ (Cleveland) Sprint endura (single lead) and extensa (dual lead) peripheral nerve stimulation (PNS) systems. The minimally invasive Sprint system is the only FDA-approved percutaneous PNS system that is indicated for up to 60 days in the back and/or extremities for both chronic and acute pain and is the industry’s only

ARTMS’ system may ease cost, shortage of valuable radioisotopes

ARTMS Products (Vancouver, B.C) has won the CE mark for its first-in-class, advanced technology Quantm irradiation system, designed to produce high-value medical imaging isotopes such as technetium-99m (Tc-99m) on medical cyclotrons. Tc-99m is given to nearly 50,000 Americans every day to diagnose cancer and heart disease. It is used in more than 80% of all nuclear